Use "BPC-157 Dosage Guide: Protocols & Safety 2026" to make the conversation more specific before you choose a provider, product, or next step
Vascular peptides like Vesugen work through somewhat similar angiogenic mechanisms, if youre curious about that side of things
AOD-9604 adds a lipolytic component without further IGF-1 increase , useful in research contexts where you want lipolysis but not systemic anabolism
Preclinical safety evaluation across rodents, dogs, and rabbits found no test-related adverse effects across a wide exposure range
The percentage that reaches systemic circulation intact is estimated to be quite low, though exact figures for GHK-Cu specifically aren't well established in published literature
However, they do not address the core mechanisms of aging such as telomere shortening or cellular senescence